Search

Your search keyword '"Makita F"' showing total 65 results

Search Constraints

Start Over You searched for: Author "Makita F" Remove constraint Author: "Makita F"
65 results on '"Makita F"'

Search Results

1. An open-label, randomised, controlled trial on the benefit of hmb, L-arginine, and L-glutamine beverages and locomotion training as supportive care in the treatment of unresectable advanced hepatocellular carcinoma using lenvatinib: Hello study

2. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

3. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

4. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

5. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

6. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

7. Quality of gastric cancer care in designated cancer care hospitals in Japan

13. Hypertension as a paraneoplastic syndrome in hepatocellular carcinoma.

17. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

18. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

20. An open-label, randomized, controlled trial on the benefit of β-hydroxy-β-methyl butyrate, l-arginine, l-glutamine combination beverages and locomotion training as supportive care for the treatment of unresectable hepatocellular carcinoma using lenvatinib: A pilot study (HELLO study).

21. A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis.

22. Decreased numbers of gastric, colorectal, lung, and breast cancer surgeries performed in 17 cancer-designated hospitals in Gunma Prefecture of Japan during the COVID-19 pandemic.

23. The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study.

24. Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis.

25. Role of deleterious single nucleotide variants in the coding regions of TNFAIP3 for Japanese autoimmune hepatitis with cirrhosis.

26. POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

27. Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population.

28. Spontaneous isolated dissection of the superior mesenteric artery and aneurysm formation resulting from segmental arterial mediolysis: a case report.

29. Association of a single nucleotide polymorphism upstream of ICOS with Japanese autoimmune hepatitis type 1.

30. Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.

31. Lack of association between the CARD10 rs6000782 polymorphism and type 1 autoimmune hepatitis in a Japanese population.

32. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.

33. Association of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese population.

34. Weekly paclitaxel in combination with doxifluridine for peritoneally disseminated gastric cancer with malignant ascites.

35. A phase II study of weekly paclitaxel and doxifluridine combination chemotherapy for advanced/recurrent gastric cancer.

36. [A retrospective study of irinotecan plus fluorouracil and l-leucovorin chemotherapy for advanced and metastatic colorectal cancer].

37. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters.

38. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival.

39. [Four cases of advanced colorectal cancer successfully treated with irinotecan plus 5-fluorouracil and l-leucovorin combination chemotherapy].

40. A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patients.

41. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. .

42. A case of esophageal sarcomatoid carcinoma with molecular evidence of a monoclonal origin.

43. [A case of hepatic angiosarcoma associated with idiopathic portal hypertension].

44. [Hepatocellular carcinoma following interferon therapy].

45. [A resected case of cholangiocellular carcinoma associated with HCV antibody-positive liver cirrhosis].

46. Evaluation of the therapeutic effect of TAE on primary liver cancer.

47. [A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid].

48. Antitumor effect of RBS (rice bran saccharide) on ENNG-induced carcinogenesis.

49. [Cholangiocellular carcinoma following gallbladder carcinoma--a case report].

50. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.

Catalog

Books, media, physical & digital resources